Area of research
Infectious Diseases · Oncology
Research interest
Research interests include COVID-19 Clinical Research Studies, COVID-19 and healthcare impacts, Genetic Associations and Epidemiology, and SARS-CoV-2 and COVID-19 Research.
Bridging Genomics and Pharmacoepidemiology to Expand Treatment Options for Alcohol Use Disorder
Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake
Using Quantitative Bias Analysis to Adjust for Misclassification of <scp>COVID</scp> ‐19 Outcomes: An Applied Example of Inhaled Corticosteroids and <scp>COVID</scp> ‐19 Outcomes
Benzodiazepine and z-drug prescribing in critical care survivors and the risk of rehospitalisation or death due to falls/trauma and due to any cause: a retrospective matched cohort study using the UK Clinical Practice Research Datalink
Utility of Candidate Genes From an Algorithm Designed to Predict Genetic Risk for Opioid Use Disorder
Alcohol use disorder and body mass index show genetic pleiotropy and shared neural associations
Polypharmacy's Association With Mortality: Confounding From Underlying Morbidity
Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virus
How Should Meaningful Evidence Be Generated From Datasets?
Cannabis Use and Self-Reported Bothersome Symptoms in People with HIV
Outpatient hospital attendances in people with rheumatoid arthritis during the COVID-19 pandemic and beyond: a cohort study in three nations of the UK
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)
A multi-ancestry genetic study of pain intensity in 598,339 veterans
Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data
Quantifying possible bias in clinical and epidemiological studies with quantitative bias analysis: common approaches and limitations
Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis
Care interruptions and mortality among adults in Europe and North America
A Mendelian randomization study of alcohol use and cardiometabolic disease risk in a multi‐ancestry population from the Million Veteran Program
Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records
Four targets: an enhanced framework for guiding causal inference from observational data
Impact of COVID-19 on recorded blood pressure screening and hypertension management in England: an analysis of monthly changes in the quality and outcomes framework indicators in OpenSAFELY
Herpes Zoster and Risk of Incident Parkinson's Disease in <scp>US</scp> Veterans: A Matched Cohort Study
Psychotropic prescribing after hospital discharge in survivors of critical illness, a retrospective cohort study (2012–2019)
Patient Characteristics and Practice Variation Associated With New Community Prescription of Benzodiazepine and z‐Drug Hypnotics After Critical Illness: A Retrospective Cohort Study Using the <scp>UK</scp> Clinical Practice Research Datalink
Hypertension Control During the Coronavirus Disease 2019 Pandemic
Contribution of Potentially Inappropriate Medications to Polypharmacy-Associated Risk of Mortality in Middle-Aged Patients: A National Cohort Study
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status
Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis
Author Correction: A multi-ancestry genetic study of pain intensity in 598,339 veterans
Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform